GARCHING / MUNICH, DE & VANCOUVER, BC – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical stage biotechnology company developing differentiated and highly targeted radiopharmaceuticals, announced… Read More
Recently completed recruitment of all 7 patients in Cohort 2 Anticipates additional data from Cohort 2 of Phase 1/2 clinical trial evaluating its enhanced 10-channel Cell Pouch in patients with… Read More
Dr. John C. Bernal, DVM, joins Frontage Laboratories with over 45 years of experience in Laboratory Animal Medicine. John reports to Dr. Abdul Mutlib, CEO. John began his career as… Read More
The Terry Fox Research Institute has co-funded six Master’s and PhD students and one postdoctoral fellow as part of the Canadian Cancer Society’s inaugural Research Training Awards. Master’s and PhD… Read More
License allows PharmAla to drive revenue and growth while remaining true to its “regulatory first” mission VANCOUVER, BC – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF),… Read More
